The Biopol Chemicals SME IPO listing opened with hope. It listed at a small premium. But within minutes, the mood changed. Selling pressure took control. The stock slipped and locked in the lower circuit.
This is how the market behaved on February 13. A positive start. A sharp reversal. And a clear reminder that listing day sentiment can turn quickly.
Let’s break down the Biopol Chemicals SME IPO listing in a simple, clear way — with facts, numbers, and what actually happened on the exchange.
Market Performance: Biopol Chemicals SME IPO Listing Day Action
The Biopol Chemicals SME IPO listing took place on the NSE SME platform.
The stock opened at ₹111, compared to its issue price of ₹108. That means a 2.78% premium at the time of listing.
On the surface, it looked like a steady debut.
But markets were weak. Selling pressure emerged soon after the opening bell.
Within a short span:
- The stock erased early gains
- It touched its 5% lower circuit at ₹105.45
- Around 10:05 AM, it was down 2.36% from its issue price
- It remained locked at ₹105.45
So, despite opening above the issue price, the Biopol Chemicals SME IPO listing ended up trading below ₹108 on listing day morning.
This sharp shift reflects broader market selloff impact during the session.
Main News: How the Biopol Chemicals SME IPO Listing Unfolded?
The Biopol Chemicals SME IPO listing began on Friday, February 13.
Here’s the clear sequence of events:
- Issue Price: ₹108
- Opening Price: ₹111
- Opening Premium: 2.78%
- Lower Circuit Level: ₹105.45
- 10:05 AM Price: ₹105.45
- Change vs Issue Price: -2.36%
The stock’s move from ₹111 to ₹105.45 happened quickly.
In SME counters, volatility is not unusual. Price bands are tighter. Liquidity can be lower. That combination often results in sharp intraday movement.
This is exactly what we saw in the Biopol Chemicals SME IPO listing.
IPO Details: Structure and Subscription
Before the Biopol Chemicals SME IPO listing, the IPO itself saw solid response.
The IPO opened on February 6 and closed on February 10.
It received overall subscription of over 20 times.
Here are the core details:
- Type: Book-built SME IPO
- Total Shares Offered: 28,94,400 shares
- Issue Price: ₹108 per share
- Total Issue Size: ₹31.26 crore
- Subscription Level: Over 20x
The allotment process was completed shortly after closing.
- Likely Allotment Finalisation: February 11
- Shares Credited to Demat Accounts: February 12
- Listing Date: February 13
The timeline moved fast, as is typical with SME IPOs.
Company Details: What Biopol Chemicals Does?
Behind the Biopol Chemicals SME IPO listing is a company operating in the specialty chemicals space.
Biopol Chemicals is engaged in:
- Trading
- Manufacturing
- Distribution
Its product categories include:
- Silicones
- Emulsifiers
- Biochemicals
- Polyelectrolytes
These chemicals are used across various industrial segments.
The company operates within specialized chemical categories rather than mass commodity chemicals.
Financial Performance Before Biopol Chemicals SME IPO Listing
Financial numbers form a crucial part of any IPO story. Let’s look at the reported figures shared ahead of the Biopol Chemicals SME IPO listing.
Revenue from Operations
- FY23: ₹19.32 crore
- FY24: ₹25.47 crore
- FY25: ₹49.13 crore
Revenue increased from ₹19.32 crore in FY23 to ₹49.13 crore in FY25.
That’s more than double over three financial years.
Profit After Tax (PAT)
- FY23: ₹0.53 crore
- FY24: ₹2.96 crore
- FY25: ₹4.33 crore
Net profit also rose consistently during the same period.
From ₹0.53 crore in FY23, PAT increased to ₹4.33 crore in FY25.
The numbers indicate growth in both top line and bottom line before the Biopol Chemicals SME IPO listing.
IPO Management Details
The issue was managed by established intermediaries:
- Book Running Lead Manager: Smart Horizon Capital Advisors Private Limited
- Registrar: Bigshare Services Private Limited
They handled the process from issue structuring to allotment and listing.
Market Sentiment and Listing Day Pressure
The Biopol Chemicals SME IPO listing happened during a broader market selloff.
That context matters.
When overall markets decline:
- Risk appetite slows
- Newly listed SME stocks can face pressure
- Early premiums can disappear quickly
That’s what happened here.
A 2.78% listing premium turned into a lower circuit lock at ₹105.45 within the first hour of trading.
The movement reflects how secondary market sentiment influences IPO listings — especially in the SME segment.
Quick Snapshot: Biopol Chemicals SME IPO Listing at a Glance
For easy reference:
Listing Data
- Opened at ₹111
- Issue price ₹108
- 2.78% premium at listing
- Hit 5% lower circuit at ₹105.45
- Down 2.36% from issue price by 10:05 AM
IPO Data
- 28,94,400 shares issued
- ₹31.26 crore total issue size
- Subscription over 20 times
Financial Data
- Revenue: ₹19.32 crore (FY23) → ₹49.13 crore (FY25)
- PAT: ₹0.53 crore (FY23) → ₹4.33 crore (FY25)
Summary: What the Biopol Chemicals SME IPO Listing Shows?
The Biopol Chemicals SME IPO listing started with a mild premium of 2.78% at ₹111.
But within hours, it slipped to the 5% lower circuit at ₹105.45.
The IPO itself saw strong subscription of over 20 times and raised ₹31.26 crore through a 28.94 lakh share issue.
Financially, the company reported steady revenue growth from ₹19.32 crore in FY23 to ₹49.13 crore in FY25. Net profit also moved up from ₹0.53 crore to ₹4.33 crore during the same period.
The listing day story is simple.
A positive opening.
Immediate selling pressure.
Lower circuit lock.
The Biopol Chemicals SME IPO listing reflects how quickly listing-day sentiment can shift, especially in SME stocks during broader market weakness.
Source: Livemint
Easy & quick
Leave A Comment?